July 24-28, the World Federation of Hemophilia will be hosting its annual World Congress meeting—this time, in Orlando, Florida.
As you might imagine, many pharmaceutical and biotech companies will be attending as sponsors of certain events. The very best scientists and doctors in hemophilia research and treatment development will be presenting their findings.
This is especially exciting, because certain advanced treatments have been scheduled for FDA approval, which means they’ll hopefully be released to market this year.
To find out more, click here.